05:07 PM EDT, 08/22/2025 (MT Newswires) -- Thomas Trimarchi, President and CFO, on August 21, 2025, sold 42,237 shares in Bridgebio Pharma ( BBIO ) for $2,090,081. Following the Form 4 filing with the SEC, Trimarchi has control over a total of 421,081 common shares of the company, with 421,081 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1743881/000095017025111011/xslF345X05/ownership.xml